Literature DB >> 12006336

Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease.

G Triolo, M Vadalà, A Accardo-Palumbo, A Ferrante, F Ciccia, E Giardina, P Citarrella, G Lodato, G Licata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12006336      PMCID： PMC1754121          DOI： 10.1136/ard.61.6.560

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

Review 1.  Behçet's disease: from Hippocrates to the third millennium.

Authors:  D H Verity; G R Wallace; R W Vaughan; M R Stanford
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

Review 2.  Update on the therapy of Behçet disease.

Authors:  Zeinab Saleh; Thurayya Arayssi
Journal:  Ther Adv Chronic Dis       Date:  2014-05       Impact factor: 5.091

3.  Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement.

Authors:  Masaru Takeuchi; Hideyuki Hokama; Rintaroh Tsukahara; Takeshi Kezuka; Hiroshi Goto; Jun-Ichi Sakai; Masahiko Usui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-28       Impact factor: 3.117

4.  One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs.

Authors:  Annarita Giardina; Angelo Ferrante; Francesco Ciccia; Maria Vadalà; Ennio Giardina; Giovanni Triolo
Journal:  Rheumatol Int       Date:  2009-10-27       Impact factor: 2.631

5.  Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.

Authors:  Massimo Accorinti; Maria Pia Pirraglia; Maria Pia Paroli; Roberta Priori; Fabrizio Conti; Paola Pivetti-Pezzi
Journal:  Jpn J Ophthalmol       Date:  2007-06-07       Impact factor: 2.447

6.  Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis.

Authors:  Takeru Yoshimura; Koh-Hei Sonoda; Nobuyuki Ohguro; Yoshiyuki Ohsugi; Tatsuro Ishibashi; Daniel J Cua; Takashi Kobayashi; Hiroki Yoshida; Akihiko Yoshimura
Journal:  Rheumatology (Oxford)       Date:  2009-01-22       Impact factor: 7.580

7.  Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients.

Authors:  Fabrizio Cantini; Laura Niccoli; Carlotta Nannini; Olga Kaloudi; Emanuele Cassarà; Massimo Susini; Ivo Lenzetti
Journal:  Biologics       Date:  2011-12-29

8.  Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report.

Authors:  Salvatore Gulli; Carlo Arrigo; Loredana Bocchino; Lucia Morgante; Donatella Sangari; Irene Castagna; Gian Filippo Bagnato
Journal:  BMC Musculoskelet Disord       Date:  2003-08-28       Impact factor: 2.362

Review 9.  Review of Systemic Immunosuppression for Autoimmune Uveitis.

Authors:  Claudia Castiblanco; C Stephen Foster
Journal:  Ophthalmol Ther       Date:  2014-03-18

Review 10.  Update on the diagnosis and management of Behçet's disease.

Authors:  Ryo Rokutanda; Mitsumasa Kishimoto; Masato Okada
Journal:  Open Access Rheumatol       Date:  2014-12-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.